United States · Series A startup

Who invested in Amplimmune

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$20Mraised across 1 round since 2006, from 1 source

Latest round
Series A, $20MJan 2006
Investors
2
See who backed them

The rounds

  1. Jan 2006
    Series A$20M

    From a historical funding record

The exit

ExitBuyerPriceWhen
AcquiredAstraZeneca$500MAug 2013

From historical deal records. Wrong? Tell us.

Everyone who backed them

InterWest PartnersVC firm1round
Wellcome TrustGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Amplimmune

Who invested in Amplimmune?

Amplimmune's investors include InterWest Partners and Wellcome Trust.

How much has Amplimmune raised?

Amplimmune has raised $20M across 1 round since 2006.

When did Amplimmune last raise?

Amplimmune's most recent round was a Series A of $20M in Jan 2006.

What was Amplimmune's biggest round?

Its most recent round, $20M in Jan 2006, is also its largest on record.

Who backed Amplimmune first?

Amplimmune's first round on record, in Jan 2006, was backed by InterWest Partners and Wellcome Trust.

What stage is Amplimmune at?

Amplimmune's latest named round is a Series A, in Jan 2006.

Where is Amplimmune based?

Amplimmune is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.